HEARTCARE

Serial Number 88270544
Registration 6148374
700

Registration Progress

Application Filed
Jan 22, 2019
Under Examination
Jul 23, 2019
Approved for Publication
May 28, 2019
Published for Opposition
May 28, 2019
Registered
Sep 8, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-08)
Due: Sep 08, 2026 305 days

Trademark Image

HEARTCARE

Basic Information

Serial Number
88270544
Registration Number
6148374
Filing Date
January 22, 2019
Registration Date
September 8, 2020
Published for Opposition
May 28, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 8, 2020
Registration
Registered
Classes
005 044

Rights Holder

CareDx, Inc.

03
Address
3260 Bayshore Boulevard
Brisbane, CA 94005

Ownership History

CareDx, Inc.

Original Applicant
03
Brisbane, CA

CareDx, Inc.

Owner at Publication
03
Brisbane, CA

CareDx, Inc.

Original Registrant
03
Brisbane, CA

Legal Representation

Attorney
Theresa Conduah

USPTO Deadlines

Next Deadline
305 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-08)
Due Date
September 08, 2026
Grace Period Ends
March 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Sep 8, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 27, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 27, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 27, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 18, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 8, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 6, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 5, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 4, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 4, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 22, 2020 IUAF S USE AMENDMENT FILED Loading...
Jul 22, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 25, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 23, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 23, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 23, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 23, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 28, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 28, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 8, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 22, 2019 ALIE A ASSIGNED TO LIE Loading...
Apr 4, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 4, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 4, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 4, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 4, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 3, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 13, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 25, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic testing kits comprised of medical diagnostic reagents and assays for organ transplant surveillance, including damage, rejection, or tolerance
First Use Anywhere: Jan 31, 2019
First Use in Commerce: Jan 22, 2020
Class 044
Medical diagnostic services, namely, gene expression testing to determine immune response; medical diagnostic services, namely, cell-free DNA testing for medical purposes; medical diagnostic testing, namely, donor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing services, namely, blood-based testing to determine immune response and organ transplant rejection or tolerance
First Use Anywhere: Jan 31, 2019
First Use in Commerce: Jan 22, 2020

Additional Information

Design Mark
The mark consists of a gray square on the lower left side and a red square on the upper right side, and the gray wording "HeartCare" to the right of the design.
Color Claim
The color(s) gray and red is/are claimed as a feature of the mark.

Classification

International Classes
005 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEART CARE"